Effects of FRAX+SARC-F Pre-screening on Preventing Fragility Fracture and Fall in Community-dwelling Older Adults
The Effects of FRAX+SARC-F Questionnaire Pre-screening on Promoting Public Awareness of Fragility Fracture and Fall Prevention Among Community-dwelling Older Adults
1 other identifier
interventional
2,956
1 country
1
Brief Summary
Hip fragility fractures are a major threat to functional independence in older adults locally and globally. In Hong Kong, the prevalence of osteoporosis and osteopenia in people aged \>50 years were reported to be as high as 37% and 52%, respectively. The major challenge in fragility fracture prevention is that fragility fracture is caused by the combination of osteoporosis and propensity to fall, and both of these conditions are multifactorial. Ample evidence shows that fall risks can be reduced by well-designed exercises, and osteoporosis can be effectively diagnosed by Dual-energy X-ray Absorptiometry imaging (DXA) and treated with anti-osteoporosis medication. Lifestyle modifications e.g. diet, optimal physical activity, environmental safety can also help to prevent falls or improve bone health. The brief Fracture Risk Assessment Tool (FRAX) and SARC-F provide a low cost of prescreening for fracture risk and sarcopenia, respectively. Using SARC-F in conjunction with FRAX has increased sensitivity for hip fracture risk prediction. FRAX+SARC-F may help increase the public awareness of osteoporosis and get the at-risk group to receive diagnostic tests and be treated. This model should fit in well with the coming District Health Centres across Hong Kong.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2021
CompletedFirst Posted
Study publicly available on registry
January 14, 2021
CompletedStudy Start
First participant enrolled
May 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
ExpectedAugust 21, 2024
August 1, 2024
2.6 years
January 13, 2021
August 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
proportions of participants diagnosed with osteoporosis in the FRAX+SARC-F pre-screening and control groups.
proportions of participants diagnosed with osteoporosis in the FRAX+SARC-F pre-screening and control groups.
within 1-6 months
Secondary Outcomes (6)
Rate of receiving osteoporosis screening
6-12 months
rate of receiving fall risk assessment
6-12 months
rate of receiving anti-osteoporosis intervention
6-12 months
rate of receiving fall prevention intervention
6-12 months
subsequent fall rate
12 months
- +1 more secondary outcomes
Study Arms (2)
Pre-screening
EXPERIMENTALReceiving FRAX+SARC-F questionnaire pre-screening results on estimated fracture risk
Control
NO INTERVENTIONNot receiving FRAX+SARC-F questionnaire pre-screening preliminary results on estimated fracture risk
Interventions
Pre-screening group participants will receive the FRAX+SARC-F questionnaire pre-screening and be notified of the preliminary estimation of their future hip fracture risk before being invited to our DXA screening and fall-risk assessment.
Eligibility Criteria
You may qualify if:
- aged ≥ 65 years
- living in the community
You may not qualify if:
- cannot follow the instruction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong Jockey Club Centre for Osteoporosis Care and Control
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Timothy Kwok
The Chinese University of Hong Kong Jockey Club Centre for Osteoporosis Care and Control
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 13, 2021
First Posted
January 14, 2021
Study Start
May 7, 2021
Primary Completion
December 30, 2023
Study Completion (Estimated)
December 1, 2028
Last Updated
August 21, 2024
Record last verified: 2024-08